Visterra
Latest round
- Series C
Last raised
- Oct 2017
Total raised
- $133M
Investors
- 13
About Visterra
Founded in 2007 and based in Massachusetts, US, Visterra, Inc.) operates as a biopharmaceutical company that develops antibody-based biological medicine for the treatment of infectious diseases.
Who invested in Visterra
13 investors across 10 rounds
See all investors in Visterra
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Oct 5, 2017
Amount
$24M
Investors
Series C
Jun 1, 2016
Amount
$23M
Investors
Series B
Oct 2, 2014
Amount
$30M
Investors
Series B
May 15, 2014
Amount
$3.6M
Investors
Series A
Dec 2, 2013
Amount
$8.1M
Investors
Series A
Nov 5, 2012
Amount
$13M
Investors
Series A
Nov 2, 2012
Amount
$13M
Investors
Series A
May 14, 2012
Amount
$13M
Investors
Seed
Nov 30, 2009
Amount
$3.2M
Investors
Seed
Jan 28, 2008
Amount
$2M
Investors
Questions about Visterra
Who invested in Visterra?
Visterra has 13 investors on record across 10 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Visterra raised?
Visterra has raised 10 venture rounds. Sign up free to see how much each round raised and the total.
When did Visterra last raise money?
Visterra's most recent round on record is a Series C, in Oct 2017.
What does Visterra do?
Founded in 2007 and based in Massachusetts, US, Visterra, Inc.
Where is Visterra headquartered?
Visterra is headquartered in Waltham, US.
Which VCs invest in companies like Visterra?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Visterra's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Visterra? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.